L
Lab21
Rapidly growing healthcare diagnostics business the company’s vision is of providing personalised diagnostic testing for
About Lab21
Cambridge Clinical Laboratories (CCL), based in Cambridge, UK, specializes in providing advanced testing services to healthcare professionals globally. Operating from UKAS accredited facilities, CCL offers a wide range of molecular and viral diagnostics, next-generation sequencing, pharmacogenetic, and patient profiling tests. The company serves both NHS and private customers, ensuring fast and accurate diagnostics to improve treatment outcomes. CCL's business model revolves around offering high-quality, personalized healthcare testing options with a commitment to quick turnaround times, secure sample collection, and clear results. Revenue is generated through the provision of these specialized diagnostic services to healthcare providers and institutions.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2005
- Headquarters
- Cambridge, United Kingdom
- Employees
- 12
- Open positions
- None listed
- Dealroom signal
- 55.0/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Testing, Hard Tech, Horizon Europe, medical testing
- Client focus
- b2b
- Investment activity
- 2 companies, latest May 2011
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Jun 2014 | $44M | $44M | Novacyt | — |
| EARLY VCEquity / VC | Aug 2012 | $6.6M | $26M | Clydesdale Bank | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Lab21 is 90 monthly website visits, down 70% over the last three months. Lab21's team declined 7.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
MyconosticaCambridge, United KingdomMolecular diagnostic company focussing on the diagnosis of fungal infections of clinical importance
→
DD
Delphic DiagnosticsLondon, United KingdomPharmacology, pharmacogenetic, and virology services to pharmaceutical companies
$3Mvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
- MCMedicis Capital
Clydesdale Bank
Other known investors1 additional known investor
Novacyt
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Lab21 on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Lab21’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.